MedTrace Logo

Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies

NCT01884779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 727

Last updated 2024-09-03

No results posted yet for this study

Summary

Histoplasma capsulatum var. capsulatum histoplasmosis is the leading cause of acquired immunodeficiency syndrome (AIDS) and death in French Guiana and probably in the Amazon. The diagnosis of this disease requires invasives procedures, laboratory performance, and delays up to several weeks. The Mycotic Diseases Branch of the Centers for Disease Control and Prevention (CDC) has established a rapid, sensitive and specific ELISA test for blood and urine samples that looks interesting in endemic areas, particularly in developing countries. The study aims to measure the proportion of HIV-infected patients hospitalized or in outpatient awaiting hospitalization for a suspicion of infectious syndrome whose serum and/or urinary antigen detection tests are positive for Histoplasma capsulatum var. capsulatum.

Conditions

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Mathieu NACHER, MD, PhD · CIE 802 Inserm / DGOS

  • Stephen G VREDEN, MD, PhD · Foundation for Scientific Research Suriname (SWOS)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-07-31
Completion
2015-11-03

Countries

  • France
  • Suriname

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01884779 on ClinicalTrials.gov